These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9026367

  • 1. The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist.
    Maj J, Rogóz Z, Skuza G, Wedzony K.
    J Neural Transm (Vienna); 1996; 103(1-2):131-46. PubMed ID: 9026367
    [Abstract] [Full Text] [Related]

  • 2. The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist.
    Maj J, Rogóz Z, Skuza G, Sowińska H.
    Neuropharmacology; 1992 Jul; 31(7):685-91. PubMed ID: 1407405
    [Abstract] [Full Text] [Related]

  • 3. NR2B subunit-specific NMDA antagonist Ro25-6981 inhibits the expression of conditioned fear: a comparison with the NMDA antagonist MK-801 and fluoxetine.
    Haller J, Nagy R, Toth M, Pelczer KG, Mikics E.
    Behav Pharmacol; 2011 Apr; 22(2):113-21. PubMed ID: 21285873
    [Abstract] [Full Text] [Related]

  • 4. Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice.
    Okuyama S, Imagawa Y, Tomisawa K.
    Neuropharmacology; 1996 Apr; 35(4):467-74. PubMed ID: 8793909
    [Abstract] [Full Text] [Related]

  • 5. The non-competitive NMDA receptor blocker dizocilpine potentiates serotonergic function.
    Dall'Olio R, Gaggi R, Bonfante V, Gandolfi O.
    Behav Pharmacol; 1999 Feb; 10(1):63-71. PubMed ID: 10780303
    [Abstract] [Full Text] [Related]

  • 6. The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in rats.
    Maj J, Rogóz Z, Skuza G.
    Pol J Pharmacol Pharm; 1992 Feb; 44(3):217-26. PubMed ID: 1470560
    [Abstract] [Full Text] [Related]

  • 7. Locomotor hyperactivity induced by MK-801 in rats.
    Maj J, Rogóz Z, Skuza G.
    Pol J Pharmacol Pharm; 1991 Feb; 43(6):449-58. PubMed ID: 1687944
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of 7-OH-DPAT and apomorphine on hyperactivity induced by MK-801 (dizocilpine) in rats.
    Clements RL, Greenshaw AJ.
    Neuropharmacology; 2005 Dec; 49(7):1007-16. PubMed ID: 16005475
    [Abstract] [Full Text] [Related]

  • 9. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P, Waters N, Schmidt CJ, Carlsson A, Carlsson ML.
    J Neural Transm (Vienna); 1998 Dec; 105(4-5):365-96. PubMed ID: 9720968
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MK-801- and ethanol-induced activity in inbred long-sleep and short-sleep mice: dopamine and serotonin systems.
    Hanania T, McCreary AC, Haughey HM, Salaz DO, Zahniser NR.
    Eur J Pharmacol; 2002 Dec 20; 457(2-3):125-35. PubMed ID: 12464358
    [Abstract] [Full Text] [Related]

  • 13. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
    Ouagazzal A, Nieoullon A, Amalric M.
    Eur J Pharmacol; 1994 Jan 14; 251(2-3):229-36. PubMed ID: 8149978
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of the NMDA receptor antagonist dizocilpine on behavioral manifestations of serotonin and adrenergic antidepressants in rats.
    Pruus K, Rudissaar R, Allikmets L, Harro J.
    Methods Find Exp Clin Pharmacol; 2010 Mar 14; 32(2):123-8. PubMed ID: 20401349
    [Abstract] [Full Text] [Related]

  • 17. Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.
    Ito K, Abekawa T, Koyama T.
    Psychopharmacology (Berl); 2006 Jul 14; 186(4):525-33. PubMed ID: 16758239
    [Abstract] [Full Text] [Related]

  • 18. The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade.
    Leriche L, Schwartz JC, Sokoloff P.
    Neuropharmacology; 2003 Aug 14; 45(2):174-81. PubMed ID: 12842123
    [Abstract] [Full Text] [Related]

  • 19. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens.
    Mathé JM, Nomikos GG, Schilström B, Svensson TH.
    J Neurosci Res; 1998 Mar 01; 51(5):583-92. PubMed ID: 9512002
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.